实探第十七届中国生物产业大会：我国生物产业迈向“质变飞跃”关键期

Core Insights - The 17th China Bioindustry Conference showcased cutting-edge technologies in the biological field, emphasizing the theme "Biotechnology Empowers the Future, Biomanufacturing Reshapes the World" [1] - The conference serves as a significant booster for the development of China's bioindustry, facilitating deep integration of industry, academia, and research to accelerate technology transfer and resource integration [1] Company Highlights - Shanghai United Imaging Healthcare Co., Ltd. presented the world's first 5.0T whole-body MRI system, uMRJupiter5T, which offers high-definition imaging for precise diagnosis [1] - Wuhan Heyuan Biotechnology Co., Ltd. introduced the first recombinant human albumin injection derived from rice, which alleviates reliance on imported products and is set to achieve an annual production capacity of 12 million bottles by 2026 [2] - BGI Life Sciences Research Institute announced the global first Stereo-seqV2 technology for spatial transcriptomics, which addresses the challenges of analyzing FFPE samples and has significant implications for precision medicine [3] Technological Innovations - The conference highlighted advancements in brain-machine interface technologies, including a near-infrared brain function imaging system that is the first in China to receive NMPA certification, enabling non-invasive detection of brain activity [4][5] - The high-throughput implantable brain-machine interface system showcased by Wuhan Zhonghua Brain-Machine Fusion Technology Development Co., Ltd. features 65,000 channels for bidirectional functionality, marking a significant leap in system capabilities [5] - The NeuroTuneA1 system developed by Tongji Hospital utilizes focused ultrasound for non-invasive brain-machine treatment, with successful concept validation and animal model testing [6] Industry Trends - China's bioindustry is transitioning from "quantitative accumulation" to "qualitative leap," focusing on core technology breakthroughs, product quality upgrades, and enhancing industry chain resilience [7] - Innovations in synthetic biology and gene editing are driving rapid growth in biomanufacturing, with artificial intelligence playing a crucial role in life science innovation [7] - Future developments in the bioindustry are expected to concentrate on cutting-edge fields such as synthetic biology and brain science to build core competitive advantages [7]